Vancouver biotechnology company Zymeworks Inc. (Nasdaq:ZYME) plans to spend US$929 million in cash to buy California-based Theravance Biopharma Inc. (Nasdaq:TBPH), the companies announced Monday, June ...
Legend Biotech (LEGN) generates $1 billion in CAR-T revenue with J&J already embedded as acquirer, yet trades at roughly half its $58 analyst price target. Aleniglipron posted 16% placebo-adjusted ...
A recreation of the classic Visual Basic 6 IDE and language in C# using Avalonia. This is a fun, toy project with no commercial intent. All rights to the Visual Basic name, icons, and graphics belong ...
Patients and caregivers in the SurvivorNet community often tell us they’re eager to understand how breakthrough cancer treatments move from scientific discovery to medicines that can change lives. At ...
BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) ("Legend Biotech” or the "Company”), a global leader in cell therapy, today announced that it has ...
Power outages aren’t exactly the kind of thing you can schedule. The best you can do is be prepared. If you live in an area that’s prone to extreme weather or regular power surges, that often starts ...
Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results